Research Projects & Grants

Federal

• Pediatric heart transplantation: Transitioning to adult care (TRANSIT), Role: Investigator, Lurie Children's Hospital of Chicago, IL, (12/2016 - 12/2017) Status: Completed

For Profit Organization

• Pharmacokinetics and safety of valganciclovir (Valcyte®) in infant heart transplant recipients less than 4 months of age - protocol no. NP22523, Role: Investigator, Hoffmann-La Roche Inc., (01/2014 - 01/2015) Status: Completed
• LY333328 vs Vancomycin in skin/skin-structure infections, Role: Investigator, Eli Lilly & Co., (12/1999 - 12/2000) Status: Completed

Internal

• Low absolute lymphocyte count associated with anti-thymocyte globulin induction may be a predictor of early cytomegalovirus infection in pediatric heart transplantation, Role: Investigator, LLU Dept. of Pediatrics, (08/2024) Status: Approved
• Epstein-Barr viremia treatment with oral valganciclovir and intravenous immune globulin in pediatric cardiac transplant patients, Role: Investigator, LLU Dept. of Pediatrics, (08/2021) Status: Approved
• Retrospective evaluation of immunosuppression therapy of heart transplantation patients who received HeartMate II assist device, Role: Investigator, LLU Dept. of Pharmacy Practice, (08/2017 - 08/2018) Status: Completed
• Evaluation of treating elevated pulmonary arterial pressures with phosphodiesterase-5 inhibitors in patients with left ventricular assist device, Role: Investigator, LLU Dept. of Pharmacy Practice, (11/2015 - 11/2016) Status: Completed